中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
30期
46-47
,共2页
无症状心肌缺血%参脉注射液%丹红注射液%临床效果
無癥狀心肌缺血%參脈註射液%丹紅註射液%臨床效果
무증상심기결혈%삼맥주사액%단홍주사액%림상효과
Silent myocardial ischemia%Shenmai injection%Danhong injection%Clinical effect
目的:对无症状心肌缺血应用参脉注射液配合丹红注射液治疗的临床效果进行研究分析。方法从该院无症状心肌缺血患者中选取66例并将其分为治疗组和对照组,均为33例,对比两组患者临床治疗总有效率和治疗前后HRV变化状况。结果治疗组患者临床治疗总有效率高达90.91%同对照组患者的66.67%相比,差异有统计学意义(P<0.05)﹔对比两组患者治疗前SDNN、SDANN、rMSSD和pNN50,差异无统计学意义(P>0.05)﹔治疗后,两组患者SDNN、SDANN、rMSSD和pNN50显著优于治疗前的,且治疗组患者治疗后显著优于对照组患者的,差异有统计学意义(P<0.05)。结论在治疗无症状心肌缺血疾病临床上參脉注射液配合丹红注射液临床效果显著,其对患者临床症状具有良好改善作用。
目的:對無癥狀心肌缺血應用參脈註射液配閤丹紅註射液治療的臨床效果進行研究分析。方法從該院無癥狀心肌缺血患者中選取66例併將其分為治療組和對照組,均為33例,對比兩組患者臨床治療總有效率和治療前後HRV變化狀況。結果治療組患者臨床治療總有效率高達90.91%同對照組患者的66.67%相比,差異有統計學意義(P<0.05)﹔對比兩組患者治療前SDNN、SDANN、rMSSD和pNN50,差異無統計學意義(P>0.05)﹔治療後,兩組患者SDNN、SDANN、rMSSD和pNN50顯著優于治療前的,且治療組患者治療後顯著優于對照組患者的,差異有統計學意義(P<0.05)。結論在治療無癥狀心肌缺血疾病臨床上參脈註射液配閤丹紅註射液臨床效果顯著,其對患者臨床癥狀具有良好改善作用。
목적:대무증상심기결혈응용삼맥주사액배합단홍주사액치료적림상효과진행연구분석。방법종해원무증상심기결혈환자중선취66례병장기분위치료조화대조조,균위33례,대비량조환자림상치료총유효솔화치료전후HRV변화상황。결과치료조환자림상치료총유효솔고체90.91%동대조조환자적66.67%상비,차이유통계학의의(P<0.05)﹔대비량조환자치료전SDNN、SDANN、rMSSD화pNN50,차이무통계학의의(P>0.05)﹔치료후,량조환자SDNN、SDANN、rMSSD화pNN50현저우우치료전적,차치료조환자치료후현저우우대조조환자적,차이유통계학의의(P<0.05)。결론재치료무증상심기결혈질병림상상삼맥주사액배합단홍주사액림상효과현저,기대환자림상증상구유량호개선작용。
Objective To study and analyze the clinical effect of Shenmai injection combined with Danhong injection for the treat-ment of silent myocardial ischemia. Methods 66 cases with silent myocardial ischemia admitted in our hospital were selected and divided into the treatment group and the control group with 33 cases in each. The total effective rate of clinical treatment and changes of HRV before and after treatment of the groups were compared. Results The total effective rate of clinical treatment of the treatment group reached 90.91%, compared with 66.67% of the control group, P<0.05; comparing the SDNN, SDANN, rMSSD and pNN50 between the two groups before treatment, P>0.05; after treatment, the SDNN, SDANN, rMSSD and pNN50 of both groups were significantly better than those before treatment, and those of the treatment group were obviously better than those of the control group, P<0.05. Conclusion For the treatment of silent myocardial ischemia, Shenmai injection combined with Danhong injection is quite effective, and it can improve the clinical symptoms of the patients significantly.